1. Home
  2. ATNM vs GIFT Comparison

ATNM vs GIFT Comparison

Compare ATNM & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.19

Market Cap

36.8M

Sector

Health Care

ML Signal

HOLD

Logo RDE Inc.

GIFT

RDE Inc.

HOLD

Current Price

$1.02

Market Cap

39.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
GIFT
Founded
2000
1999
Country
United States
United States
Employees
N/A
40
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
39.0M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ATNM
GIFT
Price
$1.19
$1.02
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
247.3K
76.0K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
N/A
EPS
N/A
N/A
Revenue
$90,000.00
N/A
Revenue This Year
N/A
$8.19
Revenue Next Year
N/A
$10.30
P/E Ratio
N/A
N/A
Revenue Growth
11.11
N/A
52 Week Low
$0.95
$0.73
52 Week High
$1.95
$2.08

Technical Indicators

Market Signals
Indicator
ATNM
GIFT
Relative Strength Index (RSI) 50.67 38.06
Support Level $0.99 $0.93
Resistance Level $1.25 $1.14
Average True Range (ATR) 0.11 0.09
MACD -0.02 -0.03
Stochastic Oscillator 27.81 11.47

Price Performance

Historical Comparison
ATNM
GIFT

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About GIFT RDE Inc.

Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.

Share on Social Networks: